Osaic Holdings’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-350
Closed -$235 7674
2023
Q2
$235 Sell
350
-250
-42% -$221 ﹤0.01% 7178
2023
Q1
$833 Hold
600
﹤0.01% 7014
2022
Q4
$1K Sell
600
-1,600
-73% -$3.65K ﹤0.01% 7043
2022
Q3
$9K Hold
2,200
﹤0.01% 6091
2022
Q2
$10K Sell
2,200
-250
-10% -$2.36K ﹤0.01% 6123
2022
Q1
$29K Sell
2,450
-1,000
-29% -$13.7K ﹤0.01% 5460
2021
Q4
$69K Buy
3,450
+323
+10% +$7.22K ﹤0.01% 4896
2021
Q3
$81K Buy
3,127
+1,427
+84% +$33.6K ﹤0.01% 4718
2021
Q2
$38K Buy
1,700
+950
+127% +$23.3K ﹤0.01% 5247
2021
Q1
$18K Buy
+750
New +$23K ﹤0.01% 5570

Other funds holding NMTR

Osaic Holdings's NMTR Position: Q3 2023 in Review

Osaic Holdings sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 350 shares — an estimated $235 sold.

Osaic Holdings first reported a position in NMTR in Q1 2021 and held it in 10 quarters. The position peaked at $81K in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Osaic Holdings reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 350 9 Meters Biopharma shares in Q3 2023, an estimated $235.
  • Osaic Holdings first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 10 quarters.
  • Osaic Holdings's 9 Meters Biopharma position peaked at $81K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.